Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to see if adding GW679769 (casopitant) to ZOFRAN will
significantly decrease the number of patients who experience nausea and vomiting after
surgery.